LTC residents mount immune fight after bivalent booster shot, study shows
By
Alicia Lasek
Jan 31, 2023
Nursing home residents who receive a bivalent COVID-19 mRNA vaccine show signs of substantial immune system response to omicron variants.
Clinical briefs for Friday, April 22
By
Alicia Lasek (f3)
Apr 22, 2022
New data: AstraZeneca’s COVID-19 antibody Evusheld confers 83% protection at six months … Simple test in certain pneumonia patients could help cut broad-spectrum antibiotics use … Faster onset of...
Antibody response to SARS-CoV-2 wanes among dialysis patients
Dec 15, 2021
Prebreakthrough index RBD values of <10 and 10 to <23 associated with increased odds of breakthrough infection versus value of ≥23
Clinical briefs for Wednesday, Dec. 8
By
Alicia Lasek
Dec 08, 2021
Current antibody treatments may not protect against omicron variant, but new drugs are in development … Duodopa improves quality of life in late-stage Parkinson’s disease … CDC pours $22M into fighting...
LTC docs urge peers to rapidly increase use of COVID-19 antibody drugs
By
Alicia Lasek
Nov 03, 2021
Industry geriatricians have compiled resources for their LTC peers who have not yet come on board with monoclonal antibody treatments. Resident immunity to COVID-19 is declining, and mAbs may prevent hospital...
Clinical briefs for Thursday, Sept. 16
By
Alicia Lasek
Sep 16, 2021
U.S. to limit states’ access to COVID antibody treatments as demand rises … Aggressively reducing Alzheimer’s risk factors could mean 1.2 million fewer cases in 2050: experts … NIH launches nationwide...
J&J vaccine effective against COVID Delta variant, drugmaker says
By
Alicia Lasek
Jul 06, 2021
Johnson & Johnson’s single-shot COVID-19 vaccine prompts a “strong neutralizing antibody response” that lasts at least eight months, the drugmaker has announced.
Clinical briefs for Wednesday, June 16
By
Alicia Lasek
Jun 16, 2021
NIH spotlights promising nasal spray antibody treatment for COVID … Anticoagulation therapy linked to lower COVID death rates: study … Spurned LTC pharmacies push again to receive Provider Relief Funds...
An antibody cocktail that halts disease progression in sick COVD-19 patients has been shown to prevent the disease altogether in healthy people who live in close contact with an infected person, the drugmaker...
Clinical briefs for Friday, April 2
By
Alicia Lasek
Apr 02, 2021
New CDC data: Osteoporosis rates increase in women … Exposed to COVID? Study finds point-of-care antibody tests highly effective at detection … Ruined J&J coronavirus vaccine doses are not in circulation:...